SAMU de Paris-ICU, Necker University Hospital, Greater Paris University Hospitals, Paris, France.
Pediatric and Obstetric ICU, Necker University Hospital, Greater Paris University Hospitals, Paris, France.
Resuscitation. 2023 Sep;190:109883. doi: 10.1016/j.resuscitation.2023.109883. Epub 2023 Jun 23.
Among patients treated with extracorporeal cardiopulmonary resuscitation (ECPR) as a second line of treatment for refractory out-of-hospital cardiac arrest (OHCA), some may develop brain death and become eligible for organ donation. The objective of this study was to evaluate long-term outcomes of kidney grafts recovered from these patients.
We conducted a retrospective monocentric observational study between January 1, 2011, and December 31, 2017. We exclusively included patients eligible for planned donation after brainstem death and from whom at least one organ graft was retrieved and transplanted. We compared two groups of brain dead patients: those treated with ECPR for refractory OHCA (ECPR group) and a diverse group of patients who did not receive ECPR, from which only 5/23 (22%) had OHCA (control group). The primary outcome was one-year kidney graft survival.
We included 45 patients, 23 in the control group and 22 in the ECPR group. Although patients in the ECPR group were younger and had a lower prevalence of chronic renal disease (p = 0.01), their kidney function was more severely impaired upon admission in the ICU. A total of 68 kidney grafts were retrieved, transplanted, and studied, 34 in each study group. There was no significant difference between the two groups in terms of one-year kidney graft survival (p = 0.52).
Organ transplantation from patients treated with ECPR after refractory OHCA showed one-year kidney graft survival rates comparable to those of patients not treated with ECPR.
在接受体外心肺复苏(ECPR)作为难治性院外心脏骤停(OHCA)二线治疗的患者中,有些患者可能会发展为脑死亡,并符合器官捐献条件。本研究的目的是评估从这些患者中获得的肾脏移植物的长期预后。
我们进行了一项回顾性单中心观察性研究,时间为 2011 年 1 月 1 日至 2017 年 12 月 31 日。我们仅纳入符合脑死亡后计划性捐献条件且至少有一个器官移植物被获取和移植的患者。我们比较了两组脑死亡患者:一组为接受 ECPR 治疗难治性 OHCA(ECPR 组),另一组为未接受 ECPR 治疗的患者,其中只有 5/23(22%)患有 OHCA(对照组)。主要结局是 1 年肾脏移植物存活率。
我们共纳入了 45 名患者,其中对照组 23 名,ECPR 组 22 名。尽管 ECPR 组患者更年轻,且慢性肾脏病的患病率较低(p=0.01),但他们在 ICU 入院时的肾功能更严重受损。共获取、移植和研究了 68 个肾脏移植物,每组 34 个。两组间 1 年肾脏移植物存活率无显著差异(p=0.52)。
对难治性 OHCA 后接受 ECPR 治疗的患者进行器官移植的 1 年肾脏移植物存活率与未接受 ECPR 治疗的患者相当。